In this study, we demonstrated that EMC2 was aberrantly upregulated in breast cancer tissues, significantly enhanced the proliferation and metastasis potential of tumor cells, and increased the sensitivity of tumor cells to PDK1/AKT inhibition. The gene discussed is EMC2; the disease is breast cancer.